186826-68-6Abiraterone Related Compound 7
● Under Development
| Número de catálogo: | VL830025 |
|---|---|
| N.º CAS: | 186826-68-6 |
| Fórmula mol.:: | C47H61NO4 |
| Peso mol.:: | 704.01 g/mol |
Información adicional sobre el CAS 186826-68-6
Fármaco de origen
AbirateroneNombre IUPAC
(3ß)-16-[(3ß)-3-(Acetyloxy)androsta-5, 16-dien-17-yl]-17-(3-pyridinyl)-androsta-5, 16-dien-3-ol 3-AcetateSinónimos farmacopeicos
N/ASMILES
CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC=C4C5=C([C@]6(CC[C@H]7[C@H]([C@@H]6C5)CC=C8[C@@]7(CC[C@@H](C8)OC(=O)C)C)C)C9=CN=CC=C9)C)CInChI
InChI=1S/C47H61NO4/c1-28(49)51-33-15-19-44(3)31(24-33)9-11-35-38-13-14-39(46(38,5)21-17-40(35)44)37-26-42-36-12-10-32-25-34(52-29(2)50)16-20-45(32,4)41(36)18-22-47(42,6)43(37)30-8-7-23-48-27-30/h7-10,14,23,27,33-36,38,40-42H,11-13,15-22,24-26H2,1-6H3/t33-,34-,35-,36+,38-,40-,41-,42-,44-,45-,46-,47-/m0/s1Descripción
The compound Abiraterone Related Compound 7 is a thoroughly characterized reference standard that complies with rigorous regulatory guidelines, including those from USP, EMA, JP, and BP. It is ideal for critical applications such as analytical method development, method validation (AMV), and quality control (QC), especially in the production of Abiraterone. Designed to support both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA), this product delivers the precision required for reliable results. Additionally, it includes a detailed Structure Elucidation Report (SER), ensuring accuracy and dependability for advanced analytical purposes.
Solicitar cotización
"*" señala los campos obligatorios









